Trial Profile
Efficacy and Safety of a Double Icodextrin Dose in Elderly Incident CAPD Patients on Incremental Peritoneal Dialysis Therapy: the DIDo Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Icodextrin (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- Acronyms DIDo
- 08 Nov 2020 Status changed from active, no longer recruiting to completed.
- 02 Jun 2020 This trial has been completed in United Kingdom according to European Clinical Trials Database record.
- 28 May 2020 This trial is completed in Belgium (Global End Date: 28 Feb 2020), according to European Clinical Trials Database record.